Alexander Maxwell

Value, growth, long-term horizon, biotech
Alexander Maxwell
Value, growth, long-term horizon, biotech
Contributor since: 2013
Vringo: A Stock To Watch In 2016
MannKind: The End Of The Ride
Buy Titan Ahead Of Summer Catalyst
Update: Vringo Wins In The U.K.
Update: Dendreon Bankruptcy